Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB19162InvestigationalSmall molecule
Propafenone, (r)- is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone to Treat Atrial Fibrillation).
- Mechanism
- Curator reviewed
Pharmacologically active on Sodium channel protein and Ryanodine receptor 2
- Formula / weight
- C21H27NO3 · 341.451 g/mol (avg)
- Also known as
- (+)-(r)-propafenone · (+)-propafenone · 1-propanone, 1-(2-((2r)-2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-
Resolves to
Structure
InChIKey
JWHAUXFOSRPERK-GOSISDBHSA-NSMILESCCCNC[C@@H](O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1Targets
What you can answer from here — as of July 09, 2026
Which drugs share a target with (R)-Propafenone, and which of those have an active Phase 3 trial?